Outlook Therapeutics, Inc. (OTLK) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 127.44K | -1.21M | -91.79K | 1.51M | 0 | 0 | 170.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | -153.95% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 179.74K | 29.63K | 916.51K | 439.81K | 0 | 28.8K | 85.06K | 28.67K | 28.2K | 28.2K | 11.22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 141.04% | -2.45% | -998.52% | 29.22% | - | - | 50% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -52.3K | -1.24M | -1.01M | 1.07M | 0 | -28.8K | 85.06K | -28.67K | -28.2K | -28.2K | -11.22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | -41.04% | 102.45% | 1098.52% | 70.78% | - | - | 50% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -4196.58% | -1285.37% | 3816.19% | 100% | -2.15% | 858.33% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 13.97M | 12.25M | 16.31M | 16.81M | 12.39M | 21.58M | 22.88M | 19.56M | 18.94M | 10.32M | 12.46M | 18.14M | 6.84M | 15.69M | 13.99M | 17.02M | 18.91M | 13.15M | 13.44M | 11.47M |
| OpEx % of Revenue | 10965.78% | -1013.92% | -17765.37% | 1116.98% | - | - | 13447.25% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 9.47M | 8.61M | 10.33M | 9.68M | 7.98M | 11.95M | 10.35M | 8.36M | 5.43M | 5.79M | 7.51M | 7.04M | 6.29M | 5.83M | 5M | 5.78M | 6.69M | 3.28M | 3.5M | 2.93M |
| SG&A % of Revenue | 7434.27% | -713.02% | -11251.64% | 643.02% | - | - | 6086.15% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 4.5M | 3.63M | 5.98M | 7.13M | 4.41M | 9.66M | 12.52M | 11.2M | 13.51M | 4.53M | 4.94M | 11.1M | 544.95K | 9.86M | 8.99M | 11.25M | 12.22M | 9.87M | 9.94M | 8.54M |
| R&D % of Revenue | 3531.51% | -300.9% | -6513.74% | 473.97% | - | - | 7361.1% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.03M | -13.48M | -17.31M | -15.75M | -12.39M | -21.61M | -22.88M | -19.56M | -18.94M | -10.32M | -12.46M | -18.14M | -6.84M | -15.69M | -13.99M | -17.02M | -18.91M | -13.15M | -13.44M | -11.47M |
| Operating Margin % | -11006.82% | 1116.38% | 18863.9% | -1046.2% | - | - | -13447.25% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -13.2% | 37.59% | 24.31% | 19.5% | 34.57% | -109.31% | -83.62% | -7.84% | -176.98% | 34.2% | 10.93% | -6.56% | 63.84% | -19.3% | -4.11% | -48.36% | -49.78% | 7.34% | -34.17% | 3.4% |
| EBITDA | -14M | -13.45M | -17.28M | -15.72M | -12.36M | -21.58M | -22.85M | -19.53M | -18.91M | -10.29M | -12.45M | -18.13M | -6.83M | -15.68M | -13.94M | -16.97M | -18.86M | -13.1M | -13.39M | -11.43M |
| EBITDA Margin % | -10982.96% | 1113.89% | 18831.5% | -1044.25% | - | - | -13430.32% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -13.22% | 37.65% | 24.35% | 19.53% | 34.63% | -109.6% | -83.55% | -7.75% | -177.01% | 34.33% | 10.68% | -6.82% | 63.8% | -19.68% | -4.12% | -48.53% | -50.36% | 7.16% | -34.74% | 2.81% |
| D&A (Non-Cash Add-back) | 30.42K | 30.07K | 29.74K | 29.41K | 29.1K | 28.8K | 28.8K | 28.67K | 28.2K | 28.2K | 11.22K | 11.19K | 11K | 10.78K | 51.47K | 51.27K | 51.09K | 50.87K | 50.67K | 48.18K |
| EBIT | -14.03M | -13.48M | -14.58M | -20.1M | -12.39M | -21.61M | 5.69M | 44.41M | -18.94M | -10.32M | -16.75M | -20.68M | -6.84M | -15.69M | -13.98M | -17.02M | -18.91M | -14.11M | -13.13M | -11.94M |
| Net Interest Income | 3 | 0 | -264.16K | -49.35K | 0 | 48.88K | 239.95K | 404.59K | -3.08M | 188.68K | 305.81K | 395.23K | 187.79K | -2.45M | -361K | -357K | -418K | -352K | -269K | -257K |
| Interest Income | 3 | 0 | 0 | 0 | 0 | 48.88K | 239.95K | 404.59K | 0 | 188.68K | 305.81K | 395.54K | 187.79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 264.16K | 49.35K | 0 | 0 | 0 | 0 | 3.08M | 0 | 0 | 303 | 0 | 2.45M | 360.65K | 356.95K | 418.33K | 351.53K | 269.18K | 256.87K |
| Other Income/Expense | 9.57M | -9.57M | 2.47M | -4.4M | -33.96M | 38.98M | 28.57M | 63.97M | -95.35M | -855K | -532K | -2.53M | 186.44K | -2.97M | -357K | -516K | -793K | -1.31M | 31.15K | -722K |
| Pretax Income | -4.45M | -23.06M | -14.85M | -20.15M | -46.35M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.34M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M |
| Pretax Margin % | -3494.28% | 1909.05% | 16175.93% | -1338.75% | - | - | 3345.21% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | -1.55M | 0 | 2.8K | 0 | 0 | 0 | 2.8K | 0 | 0 | 0 | 2.8K | 0 | 800 | 0 | 2K | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 10.47% | 0% | -0.01% | 0% | 0% | 0% | -0% | 0% | 0% | 0% | -0.04% | 0% | -0.01% | 0% | -0.01% | 0% | 0% | 0% |
| Net Income | -4.45M | -23.06M | -13.29M | -20.15M | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M |
| Net Margin % | -3494.28% | 1909.05% | 14482.19% | -1338.75% | - | - | 3345.21% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 90.39% | -232.69% | -333.58% | -145.38% | 59.44% | 255.47% | 143.81% | 314.8% | -1617.6% | 40.11% | 9.44% | -17.87% | 66.23% | -29.04% | -7.02% | -43.81% | -50.34% | -0.05% | -35.09% | -304.54% |
| Net Income (Continuing) | -4.45M | -23.06M | -13.29M | -20.15M | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.38 | -0.52 | -0.55 | -1.50 | 0.72 | 0.31 | -0.89 | -8.01 | -0.86 | -1.00 | -1.61 | -0.52 | -1.60 | -1.35 | -1.60 | -1.80 | -1.60 | -1.59 | -1.40 |
| EPS Growth % | 96.37% | -152.78% | -267.74% | 38.2% | 81.27% | 183.72% | 131% | 44.72% | -1440.38% | 46.25% | 25.93% | -0.63% | 71.11% | 0% | 15.09% | -14.29% | 0% | 32.49% | 27.4% | -112.12% |
| EPS (Basic) | -0.05 | -0.38 | -0.38 | -0.55 | -1.50 | 0.72 | 0.31 | 1.91 | -8.01 | -0.86 | -1.00 | -1.61 | -0.52 | -1.60 | -1.35 | -1.60 | -1.80 | -1.60 | -1.59 | -1.40 |
| Diluted Shares Outstanding | 81.84M | 25.48M | 25.48M | 36.96M | 30.87M | 24.23M | 18.55M | 25.48M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M |
| Basic Shares Outstanding | 81.84M | 60.2M | 34.8M | 36.96M | 30.87M | 24.23M | 18.55M | 23.28M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |